CCNP 45th Annual Meeting
CCNP 45th Annual Meeting
September 21-23, 2023
Toronto, ON

Call for Symposia Proposal

Dear Colleagues:

We would like to invite you to propose symposia for the 2023 meeting of the Canadian College of Neuropsychopharmacology to be held at the Faculty Club (41 Willcocks St, Toronto, ON M5S 3G3) from September 21-23, 2023.

Symposia proposal should include:

  1. identification of the Chair(s),
  2. a brief synopsis of the symposium theme (~ half a page),
  3. a confirmed list of 3 speakers, including institutional affiliations, and
  4. tentative titles plus a brief summary of each talk (3-4 sentences).
  • Each of the 3 presentations will last 20 minutes which allow for a 15-min presentation and a 5 min discussion period.
  • An individual cannot be listed as a presenter on more than 1 submitted proposal
  • The registration fee for speakers will be waived

Symposia should focus on topics that are timely and of broad interest to the CCNP membership. Multi-institutional submissions with a translational component and a mix of junior and senior researchers are considered a strength. We encourage individuals from equity seeking groups and reflecting the diversity of Canadian society to be included as presenters.

We look forward to seeing you in Toronto!

Proposals should be emailed as Word or PDF attachments to Rachelle Anderson at

Download the PDF.

Deadline for Submission: June 20th, 2023

First Call for Abstracts

Dear Colleagues,

This is the first Call for Poster Abstracts for the Canadian College of Neuropsychopharmacology 2023 meeting to be held in downtown Toronto at the Faculty Club (University of Toronto), September 21st – 23rd , 2023. Poster submissions should include:

  • Title
  • List of authors with affiliations
  • Abstract: Introduction, Methods, Results and Conclusions (maximum 300 words)

Some abstracts will be selected for talks at The Next Generation Symposia.

Submissions with a translational component and a mix of junior and senior researchers will be consider an asset. We encourage individuals from equity seeking groups and reflecting the diversity of Canadian society to be included as presenters.

Abstracts and registration are now accepted online.

Download the PDF.

The deadline for abstract submissions is July 15th 2023

CCNP 45th Annual Meeting

Aims and Objectives of the College

The principal function of the Canadian College of Neuropsychopharmacology (CCNP) is to further research and education in neuropsychopharmacology and related fields. To achieve this function, the CCNP values open communication between membership and leadership related to governance of the CCNP, and encourages its members to support integrity, collegiality, and ethics in research. The CCNP is committed to maintaining a level of excellence in the conduct of science, supporting discovery and scientific dialogue within an environment that encourages the free expression and exchange of scientific and educational ideas. The CCNP has a tradition of providing a forum for exchange of scientific information between clinical and basic scientists, which is critical for the advancement and translation of scientific discovery in neuropsychopharmacology.


The aim of the College shall be:

a) to provide a forum for clinical and basic science researchers to discuss and exchange ideas and experience in neuropsychopharmacology and to promote the development of this science nationally and internationally.

b) to be a liaison body to educational institutions, public, industry and government organizations as well as other related scientific bodies in order to promote quality of research and treatment in this field.

Journal of Psychiatry & Neuroscience

The official journal of the Canadian College of Neuropsychopharmacology
  • The Journal of Psychiatry & Neuroscience has an impact factor of 6.19 (2020 ISI data) and is ranked at #25 out of 156 Psychiatry journals and #51 out of 273 Neuroscience journals, making it the highest ranking open access journal in biological psychiatry. .
  • Original research and reviews in basic and clinical science.
  • As an open access journal our page charges remain very reasonable with no charge for figures and we are now publishing online only for rapid publication of accepted papers. CCNP members are encouraged to consider JPN for submitting their research (
For more information, visit the website of the Canadian Medical Association.

Revue de psychiatrie & de neuroscience

La revue officielle du Collège canadien de neuropsychopharmacologie
  • Le facteur d'impact de la Revue de psychiatrie et de neuroscience atteint 6,19 (données 2020 de l'ISI), ce qui en fait le journal à accès libre le mieux coté aussi bien dans la catégorie psychiatrie que dans la catégorie neurosciences.
  • Recherche originale et analyses critiques en sciences
      fondamentales et cliniques.
  • Les articles publiés dans ce journal sont accessibles gratuitement au et via PubMed Central.
Pour obtenir des informations suplémentaires, visitez le site internet de l'Association Médicale Canadienne.